Capital One Financial’s Medtronic MDT Stock Holding History

Capital One Financial’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,694	Closed	-$212K	–	191
2021 Q3	$212K	Buy	+1,694	New	+$219K	0.03%	182

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital One Financial's MDT Position: Q4 2021 in Review

Capital One Financial sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,694 shares — an estimated $212K sold.

Capital One Financial first reported a position in MDT in Q3 2021 and held it in 1 quarter. The position peaked at $212K in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

Capital One Financial reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
Capital One Financial sold 1,694 Medtronic shares in Q4 2021, an estimated $212K.
Capital One Financial first reported a position in Medtronic in Q3 2021 and held it in 1 quarter.
Capital One Financial's Medtronic position peaked at $212K in Q3 2021.
2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Capital One Financial's 13F filing for Q4 2021, filed 9 Feb 2022.